What does BPC-157 do?
Quick answer: BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. In preclinical research, mostly animal and cell models, it has been studied in models of muscle, tendon, ligament, bone and skin repair, in gastrointestinal lesion models and in inflammatory signaling. These findings have not been established in humans, and BPC-157 is sold for laboratory research use only.
BPC-157, known as Body Protection Compound-157, is a synthetic peptide that researchers have investigated in preclinical models of tissue repair and regeneration. It is derived from a protein found in human gastric juice. Here’s a summary of what has been reported in preclinical and experimental research (primarily animal and cell models):
1. Tissue Repair in Preclinical Models
In preclinical studies, BPC-157 has been investigated in models involving several tissue types, including:
- Muscle: Animal studies have examined its effects on muscle repair following experimental injury.
- Tendons and Ligaments: Researchers have investigated BPC-157 in rodent models of tendon and ligament injury, tissues that are typically slow to repair.
- Bone: Some animal studies have examined its effects on bone repair, blood flow and tissue regeneration.
- Skin and Wounds: It has been studied in animal models of skin wounds and burns.
2. Gastrointestinal Protection
BPC-157 is often linked with gut health due to its origin in gastric juice:
- Gastric Ulcer Models: In preclinical studies, researchers have investigated its effects on experimentally induced gastric and intestinal lesions and mucosal integrity.
- Intestinal Inflammation Models: Researchers have investigated BPC-157 in animal models of intestinal inflammation and gut-lining repair.
3. Anti-inflammatory Properties of BPC-157
In preclinical studies, researchers have measured the peptide’s effects on inflammatory markers in animal models of inflammation.
4. Neuroprotection
Preliminary research suggests that BPC-157 could have neuroprotective effects, such as:
- Nerve Repair: Animal studies have investigated nerve tissue regeneration in experimental models of brain and spinal cord injury.
- Neuronal Models: Preclinical research has examined its effects on neurons under experimental stress or injury conditions.
5. Blood Vessel Growth (Angiogenesis)
BPC-157 has been shown to encourage the formation of new blood vessels (angiogenesis), in preclinical models, a process researchers study in the context of tissue regeneration and blood flow.
6. Cardiovascular Models
Preclinical studies have investigated BPC-157 in cardiovascular models, including:
- Myocardial Injury Models: Researchers have examined tissue damage in animal models of experimentally induced myocardial injury.
- Blood Pressure: Animal studies have measured blood pressure responses under experimental stress or injury conditions.
7. BPC-157 in Joint Tissue Research
Researchers have investigated BPC-157 in animal models of joint inflammation and joint-tissue injury.
8. Drug-Induced Damage Models
Preclinical studies have examined BPC-157 in animal models of organ damage induced by certain drugs (e.g., NSAIDs), including effects on the liver, kidneys and gastrointestinal tract.
Important Note on Research
Most of the effects mentioned are based on animal studies and preclinical research. These findings have not been established in humans. BPC-157 sold by Transparent Peptides is for laboratory research use only and is not for human consumption.
For laboratory research, BPC-157 is listed as lyophilized vials (BPC-157 5mg, BPC-157 10mg, BPC-157 20mg; one vial each), as capsules (30 x 500mcg and 60 x 250mcg) and as a BPC-157 Nasal Spray (30ml bottle). Research use only.
BPC-157 Peptide Structure
- BPC-157 is a 15-amino-acid peptide (pentadecapeptide) with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
- It is reported to be stable against enzymatic degradation, which is one reason it is used in preclinical research.
Comparing delivery formats? See our BPC-157 and TB-500 nasal spray vs other research formats. Research use only.
FAQ
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide (pentadecapeptide) derived from a protein found in human gastric juice. It is reported to be stable against enzymatic degradation, which is one reason it is used in preclinical research.
What has BPC-157 been studied for in research?
Preclinical studies, mostly in animal and cell models, have examined BPC-157 in models of muscle, tendon, ligament, bone and skin repair, experimentally induced gastrointestinal lesions, inflammation, nerve injury, blood-vessel formation (angiogenesis) and cardiovascular injury.
Have the BPC-157 research findings been established in humans?
No. Most of the reported effects are based on animal studies and preclinical research, and these findings have not been established in humans.
What BPC-157 formats does Transparent Peptides list?
BPC-157 is listed as lyophilized vials (5mg, 10mg and 20mg), as capsules (30 x 500mcg and 60 x 250mcg) and as a BPC-157 Nasal Spray (30ml bottle), all for laboratory research use only.
Is BPC-157 for human use?
No. BPC-157 sold by Transparent Peptides is for laboratory research use only and is not for human or veterinary consumption.
All products sold by Transparent Peptides are intended strictly for laboratory research use only (RUO). They are not for human consumption, are not drugs, foods or cosmetics, and are not intended to diagnose, treat, cure or prevent any disease. The information in this article summarizes published research and is provided for educational purposes only.


